FDA Clears QbTest for Treatment Follow-Up in Patients With ADHD

The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients.

Read More

FDA Clears QbTest

Press release, December 3, 2012

Read More